Stay updated on Pembrolizumab in Poor-Prognosis CUP Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Poor-Prognosis CUP Clinical Trial page.

Latest updates to the Pembrolizumab in Poor-Prognosis CUP Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe webpage has updated its event dates, adding new dates for 2025 while removing outdated ones, and it has replaced the name of a health service with a specific cancer center.SummaryDifference1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe webpage has been updated to reflect a new version of the clinical trial for Pembrolizumab in treatment-naïve patients with carcinoma of unknown primary site, including the addition of collaborators and a revision number. The previous detailed descriptions of the trial's methodology and participant criteria have been significantly reduced.SummaryDifference54%
- Check29 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check94 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab in Poor-Prognosis CUP Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Poor-Prognosis CUP Clinical Trial page.